ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Overview Fund Activity
Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

196 hedge funds and large institutions have $2.13B invested in Intercept Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 101 increasing their positions, 39 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
-6
Holders Change %
-2.97%
% of All Funds
4.26%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
31
Increased
101
Reduced
39
Closed
33
Calls
$103M
Puts
$92M
Net Calls
+$11.2M
Net Calls Change
+$234M

Top Buyers

1
BG
Bellevue Group
Switzerland
$56.6M
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$102M
3
SCM
Sarissa Capital Management
Connecticut
$60.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
$386M
5
CCM
Consonance Capital Management
New York
$30.9M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
2
EAM
Eventide Asset Management
Massachusetts
$0
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
$26.5M
4
Goldman Sachs
Goldman Sachs
New York
$22.1M
5
Federated Hermes
Federated Hermes
Pennsylvania
$78K
Name Holding Trade Value Shares
Change 		Shares
Change %
FHB
226
First Hawaiian Bank
Hawaii
– -$3K -28 Closed
WAM
227
Wealthspire Advisors (Maryland)
Maryland
– -$2K -16 Closed
NICM
228
Neo Ivy Capital Management
New York
– -$1K -11 Closed
CHP
229
Cable Hill Partners
Oregon
– -$1K -10 Closed
6 7 8 9
10